Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2024-07-16 Regulatory Filings
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges informing them about a change in the Corporate Identification Number (CIN) of the company. It is a formal notification related to corporate compliance and regulatory disclosure. The document does not contain any financial data, report content, or detailed analysis. It is not an annual report, earnings release, or any financial statement. It is also not a report publication announcement since it does not mention any report being published or attached. The content fits best under a general regulatory announcement category. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is short (1443 characters), supporting that it is a brief regulatory notice rather than a full report.
2024-07-16 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Surveillance Department of the National Stock Exchange of India, providing a clarification regarding a significant increase in trading volume of the company's stock. It references compliance with SEBI Listing Obligations and Disclosure Requirements and states that there is no undisclosed price-sensitive information. The document is a regulatory communication clarifying market activity rather than a financial report, announcement of voting results, or management change. It is short (2350 characters) and serves as a regulatory filing to explain market behavior. Therefore, it fits best under Regulatory Filings (RNS).
2024-07-09 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2024. It is a compliance certificate confirming no requests for dematerialization/rematerialization of shares were received during the quarter. The document is addressed to stock exchanges and signed by the company secretary and the registrar. It does not contain financial statements or detailed financial data, nor is it an announcement of a report publication. It is a regulatory compliance filing related to securities regulations. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (2447 characters), and it is a certificate, not a full report or announcement of a report publication.
2024-07-05 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window for insiders due to the upcoming declaration of unaudited financial results for the quarter ended June 30, 2024. It references the SEBI regulations on insider trading and mentions the upcoming board meeting to approve the unaudited financial results. The document does not contain any financial data or the results themselves, but is an announcement related to the timing of financial disclosures and insider trading restrictions. The document length is short (1777 characters), and it serves as a regulatory notification rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and procedural announcements.
2024-06-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held by Innova Captab Limited on May 30, 2024, discussing the financial and operational performance for Q4 and FY24. It includes management commentary, financial highlights, business segment performance, and a Q&A session with analysts. The presence of detailed financial figures, discussion of quarterly and annual results, and forward-looking statements typical of earnings calls confirms this classification. The document is not merely an announcement or summary but a full transcript of the call.
2024-06-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter to stock exchanges regarding the availability of an audio recording of the earnings call for the quarter and year ended March 31, 2024. It references Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, which governs disclosures of material events. The document does not contain financial data or the earnings results themselves, but rather provides a link to the audio recording of the earnings call. The document length is short (1748 characters) and serves as a notification rather than the actual earnings release or transcript. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about the earnings call audio availability, not the earnings release or call transcript itself.
2024-05-30 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.